Clinical Context
A typical patient is an adult with a nonhealing or complex soft-tissue wound (for example, a diabetic foot ulcer, venous stasis ulcer, or surgical dehiscence) referred to a wound care clinic or outpatient surgical practice for advanced biologic therapy. The clinician performs a wound assessment, documents wound size, depth, presence of infection, and prior treatments. After conservative measures (debridement, offloading, dressings, antibiotics as indicated) fail or when the wound meets criteria for biologic grafting, the provider prepares Q4145 (Epifix, injectable, 1 mg) for local application into the wound bed or wound margins to promote healing.
The clinical workflow includes informed consent and documentation of wound characteristics, anesthesia or local analgesia if required, preparation of the injectable product under aseptic technique, and application into the wound base or surrounding tissue. The clinician documents the exact quantity administered in milligrams, the date of service, wound measurements, and any concurrent procedures (for example, surgical debridement). The product may be billed by the supplying facility or provider using Q4145 with appropriate modifier(s) reflecting the encounter circumstances and billing responsibility. Typical site of service is an outpatient wound care center, outpatient clinic, ambulatory surgical center, or hospital outpatient department.